What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His primary scientific interests are in Multiple myeloma, Cancer research, Bortezomib, Internal medicine and Bone marrow.
His work deals with themes such as Pharmacology and Dexamethasone, which intersect with Multiple myeloma.
Kenneth C. Anderson interconnects Cell culture, Apoptosis, Protein kinase B, Signal transduction and Cell growth in the investigation of issues within Cancer research.
His Bortezomib research focuses on subjects like Proteasome inhibitor, which are linked to Cancer cell.
The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology, Surgery and Oncology.
His study in Bone marrow is interdisciplinary in nature, drawing from both Molecular biology, Stromal cell, Immune system and Peripheral blood mononuclear cell.
His most cited work include:
- A phase 2 study of bortezomib in relapsed, refractory myeloma. (2325 citations)
- Bortezomib or high-dose dexamethasone for relapsed multiple myeloma (2128 citations)
- International uniform response criteria for multiple myeloma (2049 citations)
What are the main themes of his work throughout his whole career to date?
Kenneth C. Anderson mainly focuses on Multiple myeloma, Cancer research, Internal medicine, Bortezomib and Immunology.
The concepts of his Multiple myeloma study are interwoven with issues in Bone marrow, Dexamethasone and Pharmacology.
His studies deal with areas such as Monoclonal antibody, Angiogenesis, Cytokine and In vivo as well as Bone marrow.
Within one scientific family, Kenneth C. Anderson focuses on topics pertaining to Apoptosis under Cancer research, and may sometimes address concerns connected to Cytotoxicity.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Surgery and Oncology.
His work deals with themes such as Proteasome inhibitor, Proteasome and Refractory, which intersect with Bortezomib.
He most often published in these fields:
- Multiple myeloma (50.62%)
- Cancer research (39.80%)
- Internal medicine (28.16%)
What were the highlights of his more recent work (between 2015-2021)?
- Multiple myeloma (50.62%)
- Cancer research (39.80%)
- Internal medicine (28.16%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Multiple myeloma, Cancer research, Internal medicine, Oncology and Bortezomib.
The Multiple myeloma study combines topics in areas such as Bone marrow and Transplantation.
His research integrates issues of Cell culture, Cell growth, Antigen and Immunotherapy in his study of Cancer research.
In most of his Internal medicine studies, his work intersects topics such as Gastroenterology.
Kenneth C. Anderson has included themes like Clinical trial, Survival rate, Confidence interval, Meta-analysis and Minimal residual disease in his Oncology study.
His research in Bortezomib intersects with topics in Proteasome inhibitor, Proteasome and Pharmacology.
Between 2015 and 2021, his most popular works were:
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma (828 citations)
- Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma (471 citations)
- Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group (359 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Kenneth C. Anderson spends much of his time researching Multiple myeloma, Cancer research, Internal medicine, Lenalidomide and Oncology.
Kenneth C. Anderson combines subjects such as Survival rate and Bone marrow with his study of Multiple myeloma.
His Cancer research study focuses on Stromal cell in particular.
The Internal medicine study which covers Gastroenterology that intersects with Antibody-drug conjugate and Indatuximab ravtansine.
His Lenalidomide study combines topics in areas such as Surgery, Transplantation, Progressive disease and Thalidomide.
The various areas that Kenneth C. Anderson examines in his Oncology study include Meta-analysis and Proportional hazards model.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
